OBJECTIVE: To characterize the probability and duration of viral shedding among adults given trivalent live attenuated influenza vaccine (LAIV). DESIGN: Prospective surveillance study. METHODS: Nasal wash samples were collected from adult volunteers at baseline and on days 3, 7, and 10 and between days 17 and 21 following intranasal LAIV vaccination. The presence, titer, and identification of each specific strain of influenza virus shed were determined by standard methodology. RESULTS: Twenty subjects received LAIV. No samples were positive for influenza virus at baseline. After LAIV vaccination, influenza virus was recovered from 10 of 20 vaccinees on day 3, from 1 of 18 vaccinees on day 7, and from none of the samples on days 10 or 17 through 21. Vaccinees who shed vaccine virus were significantly younger than those who did not (mean age, 26.4 vs 38.6 years; P < .01). Although the presence of specific mucosal immunoglobulin A to influenza B was associated with significantly less shedding of influenza B after vaccination (P = .02), associations of shedding with other measures of immunity were not detected. CONCLUSION: The duration of shedding of vaccine virus after LAIV in adults i s limited and may be associatedwith an individual's prior influenza vaccination history.
OBJECTIVE: To characterize the probability and duration of viral shedding among adults given trivalent live attenuated influenza vaccine (LAIV). DESIGN: Prospective surveillance study. METHODS: Nasal wash samples were collected from adult volunteers at baseline and on days 3, 7, and 10 and between days 17 and 21 following intranasal LAIV vaccination. The presence, titer, and identification of each specific strain of influenza virus shed were determined by standard methodology. RESULTS: Twenty subjects received LAIV. No samples were positive for influenza virus at baseline. After LAIV vaccination, influenza virus was recovered from 10 of 20 vaccinees on day 3, from 1 of 18 vaccinees on day 7, and from none of the samples on days 10 or 17 through 21. Vaccinees who shed vaccine virus were significantly younger than those who did not (mean age, 26.4 vs 38.6 years; P < .01). Although the presence of specific mucosal immunoglobulin A to influenza B was associated with significantly less shedding of influenza B after vaccination (P = .02), associations of shedding with other measures of immunity were not detected. CONCLUSION: The duration of shedding of vaccine virus after LAIV in adults i s limited and may be associatedwith an individual's prior influenza vaccination history.
Authors: Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh Journal: Biol Blood Marrow Transplant Date: 2009-10 Impact factor: 5.742
Authors: M E Cole; R Kundu; A F Abdulla; N Andrews; K Hoschler; J Southern; D Jackson; E Miller; M Zambon; P J Turner; J S Tregoning Journal: Clin Exp Immunol Date: 2021-01-13 Impact factor: 5.732
Authors: Constantina Boikos; Lawrence Joseph; Christine Martineau; Jesse Papenburg; David Scheifele; Larry C Lands; Gaston De Serres; Mark Chilvers; Caroline Quach Journal: Open Forum Infect Dis Date: 2016-08-30 Impact factor: 3.835
Authors: Nikki E Freed; Christopher A Myers; Kevin L Russell; Elizabeth A Walter; Marina Irvine; Robert G Coon; David Metzgar Journal: Mol Cell Probes Date: 2006-09-08 Impact factor: 2.365
Authors: Natalia A Ilyushina; Mine R Ikizler; Yoshihiro Kawaoka; Larisa G Rudenko; John J Treanor; Kanta Subbarao; Peter F Wright Journal: J Virol Date: 2012-08-22 Impact factor: 5.103